Health

Organon invests 7.3 million euros in Claria Medical

Kevin Ali, CEO of Organon.

Organon has announced a strategic investment in Claria Medical, a private company developing a investigational medical device for use during laparoscopic hysterectomy minimally invasive, for 8 million dollars (7.3 million euros).

The agreement also grants Organon the option to acquire Claria Medical. The $8 million advance payment will be classified as a 2023 research and development expense.

“Hysterectomy is one of the most commonly performed surgeries on womenTherefore, it is essential to invest in new technologies with the aim of providing safer, simpler and faster procedures”, said Kevin Ali, CEO of Organon.


Improve women’s health

“Collaborations such as our agreement with Claria Medical are an integral part of our approach to business development. We seek possible solutions to improve women’s health wherever they are available, be they medicines, devices or other technologies. This agreement is based on our device expertise and aligns with our focus on advancing the achievement of urgently needed innovations“, has added.

Claria’s initial research device, the ‘Claria System’, uses an intelligent uterine containment and extraction system which aims to improve the hysterectomy procedure for both patients and physicians. The device was selected for inclusion in the Safer Technologies Program (STeP, Safer Technologies Program) of the United States Food and Drug Administration (FDA), a collaborative program that seeks to reduce the time it takes to obtain marketing authorization for eligible devices.

“Our team is excited about this strategic agreement with Organon, as they provides extensive knowledge on women’s health. Organon’s investment reinforces the potential of our technology to help improve outcomes for women. We are very much looking forward to continuing our clinical program for the Claria System and obtaining FDA clearance,” added Alexey Salamini, CEO of Claria Medical.

The information published in Redacción Médica contains affirmations, data and statements from official institutions and health professionals. However, if you have any questions related to your health, consult your corresponding health specialist.

Source link

Elton Gardner

Elton Gardner is a seasoned writer and editor for D1SoftballNews.com. He is a graduate of a prestigious journalism school and has contributed to numerous newspapers and magazines. Elton is an expert in various fields, including sports, entertainment, and technology. He is widely respected for his insights and engaging writing style. As an editor, Elton oversees a team of writers and ensures the website stays current with the latest trends and breaking news. His writing is characterized by its depth, clarity, and accessibility. Elton's spare time is spent with his family, playing sports, reading, and traveling to explore new cultures. With his talent, experience, and dedication, Elton Gardner is a prominent figure in online media and will continue to make waves in the years to come.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button